首页 > 

gun online game

2025-01-25
gun online game
gun online game Liquid Wind raises €44 million in Series C financing with Uniper, HYCAP and Samsung Ventures to meet increasing demand for low-carbon eFuelsRackmount Monitor Drawer Market Outlook and Future Projections for 2030Texas Parks and Wildlife’s Toyota ShareLunker program archives are bustling with big bass records dating back nearly four decades. Through mid-December, the popular spawning and genetics research program had taken in 3,856 entries between 8 and 18.18 pounds. It’s an impressive list representing 175 different public reservoirs, several private lakes and an army of anglers who have participated since the program’s inception in 1986. Lawrence Lee of Tolar knows his way around the Toyota ShareLunker mobile entry app way better than most. The electronic app allows anglers to use a Smartphone to enter qualifying fish weighing at least eight pounds or 24 inches in multiple categories over the course of the year. Fish also can be entered online at texassharelunker.com . Lee has entered 69 bass weighing upwards of eight pounds in the program during 2024 alone. His single year total is more than twice the number of fish entered by the program’s No. 2 contributor, Deric Miller of Southlake. Miller has registered 35 entries spanning 2018-23 from three different lakes — Fairfield, Mill Creek and Purtis Creek, according to Natalie Goldstrohm, Toyota ShareLunker program coordinator. Miller’s list is an impressive one, but Lee is on a different level. His resume includes 36 eight pounders, 15 nine pounders, 10 10 pounders, two 11 pounders, one 12 pounder and four heavyweights over 13 pounds. Sixty-eight of Lee’s fish were caught from Lake J.B. Thomas since last January, including a 13.79 Legacy Lunker that ranks as the official lake record. The remaining trio of teeners were Legend Class lunkers caught outside the program’s Jan. 1 - March 31 collection season for spawning fish. Lee’s remarkable track record lands him in pretty tall cotton. Not only has he recorded more ShareLunker entries than anyone. He is also the first angler in the history of the program to enter four fish over 13 pounds during the same calendar year. Mr. Big Fish “Mr Big Fish” might be a befitting title for the 33-year-old angler. Clayton Gladfelter called him an animal. “Some people like fishing and some people love fishing, but Lawrence Lee lives fishing, " Gladfelter chuckled. “He eats, lives and breathes fishing more than any angler I have ever met. I guess that’s why we hit it off so well and became such good friends. He’s got a fish brain, just like me.” Gladfelter is a fishing guide and forward-facing sonar expert from Albuquerque, N.M., who first discovered big bass nirvana at J.B. Thomas during spring 2023. He has since relocated to Abilene to be closer to the remote West Texas fishery 12 miles southwest of Snyder. The 28-year-old angler has steered dozens of clients to their personal bests over the last 18 months. Lee’s Legacy Lunker is among them. Gladfelter said he first met Lee at a bass tournament in 2020. One thing led to another and the two men eventually went fishing together on Lake O.H. Ivie, where Gladfelter was guiding at the time. Lee landed a 12 pounder on the first cast of the morning. “We hit it off right then,” Gladfelter said. “We’ve fished quite a bit since. He’s one of most skilled anglers I have ever had in the boat. He’s a fishing machine.” Lunkers Galore The guide believes Lee’s ShareLunker entry resume represents only a small fraction of the eight pounders he has caught this year. “He’s caught hundreds of them,” Gladfelter said. “We fun fish a lot together and we don’t weigh or submit (to ShareLunker) half of the eight pounders we catch. And we catch a bunch of ‘em.” Lee agreed. He claims he has logged numerous days fishing alone when 20 or more fish over eight pounds hit the deck. Most were caught at J.B. Thomas using forward-facing sonar to single out individual fish amid dense clouds of bait fish, small carp, catfish and crappie. He has also reeled in scads of big ones at other lakes he had rather not name or advertise for fear of attracting boat traffic. “We’re spoiled out there at J.B. Thomas — an 8-9 pounder doesn’t mean much to us anymore,” Lee said. “If it’s not at least a 10 pounder, I usually just throw it back without bothering to weigh it. I don’t know the exact numbers, but I would guess I’ve caught close to 500-600 bass over eight pounds this year.” A Sleepless Angler If it sounds like Lee is obsessed with chasing the big bite, that’s because he is. The angler claims he fishes 2-3 days a week and still holds down a full-time job doing rotating shift work at the Comanche Peak Nuclear Power Plant in Glen Rose. The job typically demands about 55-70 hours per week. Lee says it is not uncommon for him to pull a 12 hour night shift, drive four hours to the lake and fish well into the night before taking time for a short nap. Then he’ll fish more and head back to work for another 12 hour shift. “I’m addicted,” he said. “I don’t do much sleeping at all. Twice a week I’ll stay up for 24 hours. Instead of wasting time sleeping when I’m off work I just stay up and go fishing. A lot of times I’ll show up at the lake after I’ve been awake for 15-17 hours. That’s pretty much my routine.” It’s a mindset that has paid off with a bounty of big bass. Matt Williams is a freelance writer based in Nacogdoches. He can be reached by email, mattwillwrite4u@yahoo.com . Outdoors Briefs Winter rainbow trout stockings underway statewide By Matt Williams Outdoors Writer Texas Parks and Wildlife’s annual winter rainbow trout stocking program is underway statewide. Between now and early March, TPWD will release more than 342,000 hatchery raised rainbow at dozens of community lakes and ponds, state park waters and 18 Neighborhood Fishin’ lakes. The cold water fish are stocked on a put-and-take basis. Anglers are encouraged to keep their daily limit of five trout (no minimum size) on most waters, because the fish are unable to survive the warm weather months. The exceptions are special trout management zones on the Guadalupe River downstream of Canyon Lake. Texas does not require a fishing license for youth under the age of 17, but adults must have a fishing license with a freshwater fishing endorsement. Licenses and endorsement requirements are waived at state park waters. Rainbow are fairly easy to catch using small spinners, worms, manufactured dough baits and corn kernels. Light tackle with a small diameter line and a small hook are advised. Dates and locations of upcoming stockings are listed on TPWD’s website. No-cull crappie at Fork and ‘Pines Crappie fishermen headed to Lake Fork and Lake O’ the Pines between now and February 28 are reminded of a special wintertime “no cull” regulation currently in effect on those two impoundments. From December 1 to February 28, anglers are required to keep every crappie they catch, up to a legal limit of 25 fish, regardless of size. It is illegal to release any crappie on either lake during the three-month period. Both lakes will return to the statewide 25-fish, 10-inch rule on March 1. The special regulation was implemented in 1991 to curtail the perceived waste of fish that die from over-inflated air bladders (called barotrauma) as the result of being pulled quickly out of deep water.

Tanner, Charles connect for 2 TDs and Robert Morris tops Stonehill 31-13

Tesla’s Innovative Robot Takes Center Stage Tesla has once again made headlines with its humanoid robot, Optimus, making its debut in a viral video as it attempts to navigate a challenging terrain. Released on Instagram, the clip displays Optimus awkwardly tackling an uneven path, its movements reminiscent of a toddler’s uncertain steps or a person struggling to regain their balance after a night out. Humor Meets Technology The internet immediately responded with humor and speculation. Social media erupted with entertaining comments, drawing parallels between the robot’s stumbling gait and everyday human experiences. Observations ranged from quips about late-night escapades to tongue-in-cheek judgments about the robot’s sobriety. Many users even speculated that Tesla deliberately designed the robot’s imperfect movements to make it appear more relatable and less intimidating. Beyond the Laughs: A Glimpse into the Future Despite the comedic takes, the video underscores significant advancements in Tesla’s quest for humanoid robotics. The fact that Optimus manages to regain its balance after stumbling indicates notable strides in robotic mobility and balance. Tesla envisions a future where such robots can undertake repetitive or hazardous tasks, freeing humans to engage in more creative and intellectually stimulating activities. The Road Ahead for Humanoid Robotics While opinions remain divided on the implications of robots like Optimus, there’s no denying the potential they hold for transforming industries. Even in its developmental phase, Optimus’s clumsy, yet promising, performance is a step toward achieving human-like agility in robotics, paving the way for future innovations. Revolutionizing Robotics: Tesla’s Bold Leap with Optimus In a captivating display of technology pushing boundaries, Tesla has introduced its humanoid robot, Optimus, to the world, sparking a wave of curiosity and excitement. While much of the internet’s response was comedic, this unveiling marks a significant move in humankind’s quest to integrate robotics into daily life. As Tesla continues to innovate, understanding the potential and limitations of such advancements becomes crucial. Features and Innovations The release of Optimus showcases several cutting-edge features and technological advancements. Despite its somewhat humorous debut, the robot’s ability to regain balance after stumbling is a testament to the sophisticated algorithms developed by Tesla. These include real-time decision-making capabilities and the use of sensors for environment navigation, which are still groundbreaking feats in robotics. Use Cases Beyond Entertainment Tesla envisions a multitude of practical applications for Optimus. Its potential to perform repetitive, dangerous tasks shows promise across various sectors, including manufacturing and logistics. By assuming roles that are labor-intensive or harmful, Optimus could significantly reduce human involvement in high-risk environments, thus enhancing workplace safety and productivity. Pros and Cons of Tesla’s Optimus Pros: – Innovation in Mobility : The robot’s ability to navigate uneven terrains demonstrates advanced mobility solutions. – Automation Potential : Optimus could streamline operations and boost efficiency by handling mundane tasks. – Safety Enhancement : Robots in hazardous roles can minimize human exposure to dangers. Cons: – Developmental Stage : As evidenced by its stumbling, significant refinement is required. – High Costs : The integration of such robots could entail substantial financial investments. – Societal Impact : The replacement of human roles with robots poses ethical and employment concerns. Future Predictions and Market Insights The journey from concept to reality for humanoid robots like Optimus is one filled with challenges and opportunities. The robotics market is anticipated to grow exponentially, with increased investments in AI and automation. Tesla’s foray into the field signals a shift toward more dynamic and human-like machines, aligning with broader market trends. Security and Ethical Considerations As robotics become more pervasive, emphasizing security is paramount. Protecting data privacy and ensuring control over robotic functions will be essential in preventing misuse. Ethical considerations will also come to the fore, requiring thoughtful dialogue on the role of robots in society. Tesla’s Optimus exemplifies the blend of humor and innovation that often accompanies technological breakthroughs. While still in its nascent stages, the potential impact on various industries is undeniable. As Tesla continues to refine Optimus, the world watches with eager anticipation for what the future holds in humanoid robotics. For more information, explore Tesla’s innovations at Tesla .

Empowered Funds LLC lifted its holdings in TG Therapeutics, Inc. ( NASDAQ:TGTX – Free Report ) by 3.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 46,431 shares of the biopharmaceutical company’s stock after buying an additional 1,386 shares during the quarter. Empowered Funds LLC’s holdings in TG Therapeutics were worth $1,086,000 as of its most recent SEC filing. Several other institutional investors also recently modified their holdings of TGTX. Sei Investments Co. bought a new position in shares of TG Therapeutics during the first quarter valued at approximately $591,000. Russell Investments Group Ltd. grew its stake in shares of TG Therapeutics by 133.5% in the 1st quarter. Russell Investments Group Ltd. now owns 52,339 shares of the biopharmaceutical company’s stock worth $796,000 after buying an additional 29,923 shares during the last quarter. ProShare Advisors LLC increased its position in TG Therapeutics by 8.5% during the 1st quarter. ProShare Advisors LLC now owns 24,914 shares of the biopharmaceutical company’s stock valued at $379,000 after buying an additional 1,961 shares in the last quarter. State Board of Administration of Florida Retirement System raised its stake in TG Therapeutics by 10.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 43,283 shares of the biopharmaceutical company’s stock valued at $651,000 after buying an additional 4,120 shares during the last quarter. Finally, Lazard Asset Management LLC bought a new stake in TG Therapeutics in the first quarter worth $91,000. 58.58% of the stock is currently owned by institutional investors. TG Therapeutics Stock Performance Shares of TGTX opened at $35.07 on Friday. The firm has a market capitalization of $5.46 billion, a P/E ratio of -350.70 and a beta of 2.19. The company has a debt-to-equity ratio of 1.27, a current ratio of 4.59 and a quick ratio of 3.91. TG Therapeutics, Inc. has a one year low of $12.30 and a one year high of $36.50. The business has a fifty day moving average of $25.62 and a 200 day moving average of $21.64. Analysts Set New Price Targets TGTX has been the subject of several recent analyst reports. TD Cowen initiated coverage on TG Therapeutics in a research report on Tuesday, October 29th. They issued a “buy” rating and a $50.00 price target for the company. The Goldman Sachs Group lifted their target price on shares of TG Therapeutics from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday, November 5th. B. Riley increased their price target on shares of TG Therapeutics from $29.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Finally, HC Wainwright boosted their price objective on shares of TG Therapeutics from $49.00 to $55.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $37.67. Read Our Latest Analysis on TGTX Insider Activity at TG Therapeutics In other news, Director Sagar Lonial sold 5,000 shares of TG Therapeutics stock in a transaction on Monday, November 11th. The shares were sold at an average price of $30.44, for a total transaction of $152,200.00. Following the transaction, the director now owns 100,195 shares in the company, valued at $3,049,935.80. This trade represents a 4.75 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink . 10.50% of the stock is currently owned by company insiders. About TG Therapeutics ( Free Report ) TG Therapeutics, Inc, a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. Read More Want to see what other hedge funds are holding TGTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TG Therapeutics, Inc. ( NASDAQ:TGTX – Free Report ). Receive News & Ratings for TG Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TG Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter .

No. 11 Tennessee crushes UTEP to enhance CFP chances

Previous: bingo online game
Next: